Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study
Recruiting · NCT04371913 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of the study is to investigate the feasibility of enabling a second chance for breast conservation in patients with in-breast recurrences after a previous lumpectomy and RT, investigators propose to test partial breast irradiation with the target volume encompassing the entire surgical bed with 1.0-1.5 cm margins. An additional goal of the study is to investigate the feasibility of enabling a second chance for breast conservation in patients with inbreast recurrences after a previous lumpectomy and PBI, the investigators propose to test whole breast RT (WBRT) with the target as the whole breast volume.
Who can take part
Inclusion criteria
- Isolated ipsilateral unifocal breast lesions
- Limited size (\< 2-3 cm) without evidence of skin involvement
- Histologically proven invasive breast carcinoma or carcinoma in situ
- Negative histologic margins of resection
- Patients with 0 to 3 positive axillary lymph nodes without extracapsular extension
- No synchronous distant metastases
- Age ≥ 18 years
- ≥ 12 months interval between initial breast conserving therapy (surgery and whole breast radiotherapy) and recurrence
- Previous WBI or IORT, brachytherapy or external beam partial breast treatment
- Technical feasibility
- Every kind of systemic therapy is allowed
- Informed consent for clinical and research purposes signed
Exclusion criteria
- Regional recurrences (axillary, supraclavicular)
- Positive histologic margins at resection
- Metastatic disease
- Poor cosmesis from previous surgery and RT
- Extensive Intraductal Component
Where it is running
3 locations listed across 1 US state.
- New York Presbyterian Brooklyn Methodist Hospital - Brooklyn, New York, United States
- New York Presbyterian Hospital - Queens - New York, New York, United States
- Weill Cornell Medicine - New York, New York, United States